PharmaResearch (CEO Thinkyou Kim, Ki-seok Kang) celebrated the launch of REJURAN® (DOT PN) in the Philippines at the Shangri-La The Fort, Manila on the 19th of last month.
The symposium, organized by the Tritan Ventures Inc. (Tritan Med), a local partner company of PharmaResearch, welcomed 400 esteemed local dermatologists in the Philippines.
The event also featured distinguished speakers, including Dr. Michael J. Kim of the AEON Medical and Aesthetic Center in Singapore and Dr. Hyun-jun Park of the Maylin Clinic Cheongdam branch (VP of Academic Affairs Committee, KALDAT), who shared invaluable insights into PharmaResearch’s patented DOT®(DNA Optimizing Technology) and REJURAN®.
An official from PharmaResearch expressed their commitment, stating, “We are dedicated to expanding our market presence through targeted marketing efforts for REJURAN® in the local market, and we firmly believe that our entry into the Philippines will pave the way for other high-potential Asian markets.”
REJURAN®, a flagship product by PharmaResearch, is a medical device that harnesses the power of polynucleotide (PN), a regenerative substance derived from salmon, by leveraging PharmaResearch’s patented DOT™. It is renowned for its effectiveness in reducing facial wrinkles. REJURAN® earned its first-ever approval as a DOT® PN medicine in the Philippines in July.
Media Contact
Company Name: Pharmaresearch
Contact Person: Seulki Kwak
Email: Send Email
Country: South Korea
Website: http://pharmaresearch.co.kr/kor/